| Clinical portrait of the SARS-CoV-2 epidemic in European patients with cancer DJ Pinato, A Zambelli, J Aguilar-Company, M Bower, CCT Sng, R Salazar, ... Cancer discovery 10 (10), 1465-1474, 2020 | 174 | 2020 |
| Prevalence and impact of COVID-19 sequelae on treatment and survival of patients with cancer who recovered from SARS-CoV-2 infection: evidence from the OnCovid retrospective … DJ Pinato, J Tabernero, M Bower, L Scotti, M Patel, E Colomba, S Dolly, ... The Lancet Oncology 22 (12), 1669-1680, 2021 | 124 | 2021 |
| Higher-order connections between stereotyped subsets: implications for improved patient classification in CLL A Agathangelidis, A Chatzidimitriou, K Gemenetzi, V Giudicelli, ... Blood, The Journal of the American Society of Hematology 137 (10), 1365-1376, 2021 | 112 | 2021 |
| Ropeginterferon alfa-2b versus phlebotomy in low-risk patients with polycythaemia vera (Low-PV study): a multicentre, randomised phase 2 trial T Barbui, AM Vannucchi, V De Stefano, A Masciulli, A Carobbio, A Ferrari, ... The Lancet Haematology 8 (3), e175-e184, 2021 | 107 | 2021 |
| Momelotinib versus danazol in symptomatic patients with anaemia and myelofibrosis (MOMENTUM): results from an international, double-blind, randomised, controlled, phase 3 study S Verstovsek, AT Gerds, AM Vannucchi, HK Al-Ali, D Lavie, ... The Lancet 401 (10373), 269-280, 2023 | 98 | 2023 |
| High mortality rate in COVID-19 patients with myeloproliferative neoplasms after abrupt withdrawal of ruxolitinib T Barbui, AM Vannucchi, A Alvarez-Larran, A Iurlo, A Masciulli, ... Leukemia 35 (2), 485-493, 2021 | 90 | 2021 |
| Biological and clinical implications of BIRC3 mutations in chronic lymphocytic leukemia F Diop, R Moia, C Favini, E Spaccarotella, L De Paoli, A Bruscaggin, ... haematologica 105 (2), 448, 2020 | 89 | 2020 |
| Second cancer in Philadelphia negative myeloproliferative neoplasms (MPN-K). A nested case-control study T Barbui, A Ghirardi, A Masciulli, A Carobbio, F Palandri, N Vianelli, ... Leukemia 33 (8), 1996-2005, 2019 | 85 | 2019 |
| Presenting features and early mortality from SARS-CoV-2 infection in cancer patients during the initial stage of the COVID-19 pandemic in Europe DJ Pinato, AJX Lee, F Biello, E Segui, J Aguilar-Company, A Carbo, ... Cancers 12 (7), 1841, 2020 | 77 | 2020 |
| Time-dependent COVID-19 mortality in patients with cancer: an updated analysis of the OnCovid registry DJ Pinato, M Patel, L Scotti, E Colomba, S Dolly, A Loizidou, J Chester, ... JAMA oncology 8 (1), 114-122, 2022 | 70 | 2022 |
| Outcomes of the SARS-CoV-2 omicron (B. 1.1. 529) variant outbreak among vaccinated and unvaccinated patients with cancer in Europe: results from the retrospective, multicentre … DJ Pinato, D Ferrante, G Hanbury, M Bower, R Salazar, O Mirallas, ... The Lancet Oncology 23 (7), 865-875, 2022 | 60 | 2022 |
| Efficacy of recombinant erythropoietin in autoimmune hemolytic anemia: a multicenter international study B Fattizzo, M Michel, A Zaninoni, JA Giannotta, S Guillet, H Frederiksen, ... Haematologica 106 (2), 622, 2021 | 56 | 2021 |
| Use of eltrombopag in aplastic anemia in Europe M Ecsedi, É Lengline, C Knol-Bout, P Bosman, DJ Eikema, B Afanasyev, ... Annals of hematology 98, 1341-1350, 2019 | 53 | 2019 |
| Effect of ibrutinib treatment on hemolytic anemia and acrocyanosis in cold agglutinin disease/cold agglutinin syndrome M Jalink, S Berentsen, JJ Castillo, SP Treon, M Cruijsen, B Fattizzo, ... Blood, The Journal of the American Society of Hematology 138 (20), 2002-2005, 2021 | 47 | 2021 |
| Systemic pro-inflammatory response identifies patients with cancer with adverse outcomes from SARS-CoV-2 infection: the OnCovid Inflammatory Score GM Dettorre, S Dolly, A Loizidou, J Chester, A Jackson, U Mukherjee, ... Journal for ImmunoTherapy of Cancer 9 (3), 2021 | 44 | 2021 |
| Second cancers in MPN: Survival analysis from an international study M Marchetti, A Ghirardi, A Masciulli, A Carobbio, F Palandri, N Vianelli, ... American journal of hematology 95 (3), 295-301, 2020 | 43 | 2020 |
| Real-world use of thrombopoietin receptor agonists in older patients with primary immune thrombocytopenia F Palandri, E Rossi, D Bartoletti, A Ferretti, M Ruggeri, E Lucchini, ... Blood, The Journal of the American Society of Hematology 138 (7), 571-583, 2021 | 42 | 2021 |
| Determinants of enhanced vulnerability to coronavirus disease 2019 in UK patients with cancer: a European study DJ Pinato, L Scotti, A Gennari, E Colomba-Blameble, S Dolly, A Loizidou, ... European Journal of Cancer 150, 190-202, 2021 | 42 | 2021 |
| Is the absence of JAK2V617F mutation a risk factor for bleeding in essential thrombocythemia? An analysis of 106 patients A Patriarca, F Pompetti, R Malizia, O Iuliani, I Di Marzio, A Spadano, ... Blood Transfusion 8 (1), 21, 2010 | 42 | 2010 |
| Precision medicine management of chronic lymphocytic leukemia R Moia, A Patriarca, M Schipani, V Ferri, C Favini, S Sagiraju, W Al Essa, ... Cancers 12 (3), 642, 2020 | 41 | 2020 |
